Longitudinal Outcomes of Dolutegravir-based Antiretroviral Therapy in a Large Nigerian Programmatic HIV Cohort, 2017–2019
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
In a retrospective Nigerian cohort of 33,982 PLHIV initiating or switching to TLD, virological suppression reached 80–82% among participants with available viral load data and 63–65% by intention-to-treat analysis. Suppression was higher among switchers, while age and gender predicted suppression.
Description
Keywords
Journal Title
Open Forum Infectious Diseases
Conference Name
Journal ISSN
2328-8957
2328-8957
2328-8957
Volume Title
Publisher
Oxford University Press
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Wellcome Trust Senior fellowship (WT108082AIA).